Novavax, Inc.
NVAX
$10.64
$0.565.56%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 108.66% | -290.01% | -79.46% | 740.07% | 33.20% |
| Total Depreciation and Amortization | -22.17% | -12.93% | -9.32% | -33.37% | -1.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -91.59% | 11,553.49% | -104.43% | 148.41% | -446.71% |
| Change in Net Operating Assets | -144.42% | 169.04% | 67.51% | -1,420.37% | 7.11% |
| Cash from Operations | -136.62% | 184.58% | 31.29% | -7.13% | -19.58% |
| Capital Expenditure | -2.93% | -716.60% | 79.75% | 36.85% | -40.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 116.77% | -220.81% | 254.43% | -54.37% | -240.32% |
| Cash from Investing | 115.00% | -222.89% | 251.53% | -150.91% | 351.26% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -537.60% | -60.78% | 72.19% | 20.14% | -438.28% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 92.61% | -191.93% | 200.00% | -- | -- |
| Cash from Financing | -115.56% | 4,180.96% | 85.27% | -106.34% | -3,427.84% |
| Foreign Exchange rate Adjustments | -359.73% | -91.68% | 950.11% | 91.32% | -277.79% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -289.95% | 251.35% | 96.44% | -516.27% | 59.53% |